Literature DB >> 6872316

Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes.

P Hersey, S Lawrence, D Prendergast, C Bindon, W Benson, P Valk.   

Abstract

A case of Sjögren's syndrome with the sicca complex is presented which was associated with persistently low or absent C4 levels, high levels of circulating immune complexes and abnormal reticuloendothelial clearance of damaged or IgG antibody sensitized autologous red blood cells (RBCs). Investigation of normal relatives of the patient revealed low C4 levels and abnormal reticuloendothelial clearance of damaged or sensitized RBCs. HLA, A, B, DR typing revealed a high incidence of the HLA B8, DR3 haplotype and of homozygous null alleles at the C4A locus in the family members. These results suggest that the C4 deficiency and the abnormal reticuloendothelial function in the patient was in part genetically determined and may have predisposed to the development of Sjögren's syndrome. These findings serve to emphasize the possible importance of abnormal macrophage function in the pathogenesis of Sjögren's syndrome and suggest that further investigation of these aspects may increase understanding of this disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872316      PMCID: PMC1536033     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 2.  Complement genetics in relation to HLA.

Authors:  P J Lachmann; M J Hobart
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

3.  Demonstration of circulating immune complexes in Sjögren's syndrome.

Authors:  T J Lawley; H M Moutsopoulos; S I Katz; A N Theofilopoulos; T M Chused; M M Frank
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

4.  Chido-substance in plasma.

Authors:  J Middleton; M C Crookston
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

5.  A laboratory model for Sjögren's syndrome.

Authors:  H S Kessler
Journal:  Am J Pathol       Date:  1968-03       Impact factor: 4.307

6.  Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.

Authors:  M M Frank; M I Hamburger; T J Lawley; R P Kimberly; P H Plotz
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

7.  Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance.

Authors:  M I Hamburger; H M Moutsopoulos; T J Lawley; M M Frank
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

8.  Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange.

Authors:  C M Lockwood; S Worlledge; A Nicholas; C Cotton; D K Peters
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

9.  Nephelometric detection of circulating immune complexes using monoclonal rheumatoid factor.

Authors:  H Whitsed; W H McCarthy; P Hersey
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

10.  Sjögren's syndrome association with HLA-Dw3.

Authors:  T M Chused; S S Kassan; G Opelz; H M Moutsopoulos; P I Terasaki
Journal:  N Engl J Med       Date:  1977-04-21       Impact factor: 91.245

View more
  2 in total

1.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.

Authors:  O Meyer; G Hauptmann; G Tappeiner; H D Ochs; F Mascart-Lemone
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

2.  Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review.

Authors:  Donald Levy; Timothy Craig; Paul K Keith; Girishanthy Krishnarajah; Rachel Beckerman; Subhransu Prusty
Journal:  Allergy Asthma Clin Immunol       Date:  2020-05-27       Impact factor: 3.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.